Rituximab + immunotherapy in follicular lymphoma

Condition:   Follicular Lymphoma Interventions:   Drug: Rituximab;   Drug: Utomilumab;   Drug: Avelumab;   Drug: PF04518600 Sponsors:   Dana-Farber Cancer Institute;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials